Agilent: Katharine Knobil

Agilent has appointed Katharine Knobil as the firm's first chief medical officer. Prior to Agilent, Knobil served as CMO and head of research and development at Kaleido Biosciences. Knobil has also served in a variety of leadership positions at GlaxoSmithKline. She currently serves on the board of directors of Arena Pharmaceuticals.